Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S36 pseudogene 2 (MRPS36P2) is classified as a pseudogene, meaning it is a non-functional copy and not expected to produce a functional protein. It is related to the functional gene encoding mitochondrial ribosomal protein S36, which is a component of the small subunit (28S) of the mitochondrial ribosome involved in mitochondrial translation and protein synthesis[2][3][6]. Pseudogenes like MRPS36P2 typically arise via gene duplication or retrotransposition events and generally do not have known biological, therapeutic, or disease relevance[3][4]. As such, MRPS36P2 is not considered a pharmacological or therapeutic target, and there are no known interacting drugs, mechanisms of action, roles in disease, biomarker utility, or notable safety concerns associated with this pseudogene. Its primary scientific significance lies in genomics and evolutionary studies, as the presence and characteristics of mitochondrial ribosomal protein pseudogenes can inform on evolutionary processes and gene family history[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S36 pseudogene 2 (MRPS36P2).